A vaccine composition comprising qs21, mpl, a cpg...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2425358

The present invention provides novel adjuvant formulations for use with cancer antigens. The adjuvant comprises a saponin and a immunostimulatory oligonucleotide.

La présente invention concerne de nouvelles formulations d'adjuvants prévues pour être utilisées avec des antigènes du cancer. Ces adjuvants comprennent de la saponine et un oligonucléotide immunostimulant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A vaccine composition comprising qs21, mpl, a cpg... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A vaccine composition comprising qs21, mpl, a cpg..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A vaccine composition comprising qs21, mpl, a cpg... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1582641

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.